Events

MSL Excellence is an intensive 2-day seminar covering key competencies and functions of Medical Science Liaisons (MSLs) with focus on functional competencies, communications, and value-added skills that are essential to most MSLs.

medical affairs fmsl msl excellenceMSL Excellence provides a foundational understanding of the key activities, roles, responsibilities, and requirements of the MSL, including how the MSL function works internally across the healthcare company and with external medical customers and organizations.

Due to regulatory constraints, the healthcare industry (and especially pharma) has always lagged behind in adopting social media as part of their multichannel and omnichannel brand strategies. Crafting the perfect messaging that is both compelling to HCPs and consumers, while still remaining compliant with all regulatory guidelines, presents a seemingly insurmountable challenge.

Advancing Tactical Planning ™ (ATP) focuses on implementation of the plan in a highly dynamic pharmaceutical marketplace, continuing on from where most marketing and planning programs stop. Customer access is becoming increasingly difficult for the sales force all over the globe. Ironically, even as sales forces are reduced, the pressure also has never been greater to communicate with customers and build share of voice cost-effectively. Embracing new technologies, such as the internet, while being done extensively in less-regulated industries, remains a challenge for most pharmaceutical companies. Pulling these challenges together into a cohesive whole, aligned to brand strategy, is the main outcome of Advancing Tactical Planning.

From Insights to Acumen™ (FITA) is a 2-day experiential learning program for Medical Science Liaisons (MSLs) that centers on asking more insightful questions, developing longer-term ‘engagement plans, and strategic collaborations with MTLs. MSLs also will develop an appreciation of their changing role an as MSL, particularly when supporting the success of new product launches. Finally, they will learn which insights should be shared with other functions in the company as well as externally.

“patient centricityIn this world we are now operating in, you can’t possibly be profitable if you don’t have patients at the centre of what you are doing. It’s not a sustainable business model. On the inside of our organization, I feel the momentum, and, on the outside, I feel the imperative. People are moving from thinking ‘product, product, product’ to ‘patient, patient, patient’.”

-Dr. Julie Gerberding Executive Vice President & Chief Patient Officer, Merck

Patient Centricity in Action™ brings together marketing and medical affairs, aligning them on the expectations of being ‘patient centric’. In the process, they will develop better ways for the company to improve patient outcomes in partnership with HCP’s.